Products

Sorin Group announced today the enrolment of the first three patients in a clinical trial aimed at obtaining European market approval for its ‘Perceval S’ Sutureless Aortic Heart Valve.

In the largest multicenter randomized controlled study of surgical intervention versus non-surgical care for acute vertebral compression fractures, patients undergoing balloon kyphoplasty showed superior improvement in quality of life, back function and back pain than those who were given non-surgical care.

Bone Medical Limited announced that it has had discussions with FDA on the US regulatory process for CaPTHymone™, Bone’s oral Parathoid Hormone product.

Wright Medical Group, Inc. will attend the 2009 American Academy of Orthopaedic Surgeons (AAOS) Meeting in Las Vegas, Nevada February 25-28 to highlight numerous exciting product innovations across a range of orthopaedic specialties.

Benvenue Medical, Inc., a developer of minimally invasive solutions for spine repair, announced today that it has received CE Mark approval in Europe for the Kiva™ Vertebral Compression Fracture (VCF) Treatment System.

Medtronic, Inc. today announced its acquisition of Ventor Technologies Ltd., a developer of transcatheter heart valve technologies for the treatment of aortic valve disease.

Medtronic, Inc. announced today it has signed a definitive agreement to acquire CoreValve, Inc., developer of a transcatheter, transfemoral aortic valve replacement product.

Alphatec Holdings, Inc. announced today that it had entered into a license agreement with Helix Point, LLC, which provides Alphatec Spine with rights to develop and commercialize Helifix and Helifuse, proprietary concepts for two interspinous devices to treat lumbar spinal stenosis (LSS).

Extends SBi’s wrist management portfolio Addresses most common fracture treated by hand surgeons Geometry provides optimized fit for a broad range of anatomic variations

BioSyntech, Inc., a biotechnology company developing biotherapeutic thermogels for regenerative medicine, today announced that it has appointed Mr. Louis Lemire, CA, to the to the position of Chief Financial Officer.

Bovie Medical Corporation, a manufacturer and marketer of electrosurgical products, today announced that the Company has completed numerous successful surgical procedures with its SEER tissue resection device in France, Italy, Belgium, Spain and in the United States.

CryoLife, Inc., an implantable biological medical device and tissue processing company, announced today that revenues for the year ended December 31, 2008 increased 11 percent to $105.1 million compared to $94.8 million for the year ended December 31, 2007.

The HTA (Human Tissue Authority) is announcing new rules for bone and skin products to protect patients from diseases such as HIV, Hepatitis C and CJD. The HTA already regulates the use of tissue containing cells to treat patients.

Michael Baker, the president and CEO of ArthroCare Corp., is departing his post immediately amid revelations that the company engaged in improper behavior in its insurance billing and health care compliance practices associated with its spine business unit.

Covidien Ltd. today reported results for the first quarter of fiscal 2009 (October – December 2008). First-quarter net sales rose 6% to $2.5 billion from $2.3 billion a year ago, fueled by very strong growth in Pharmaceutical Products and continued strength in Medical Devices and Medical Supplies.

The Board of Directors of Baxter International Inc. today declared a quarterly dividend of $0.26 per share of Baxter common stock.